21688 results for «»

Filter By

21688 results

RTC - Radial versus femoral access for coronary procedures

29 Aug 2022

Thirty years after the first radial access interventional coronary procedure the RTC trial provides evidence that radial access for coronary angiography or PCI is associated with lower risks of all-cause death and bleeding compared with femoral access. Mirvat Alasnag interviews Giuseppe Gargiulo regarding the methodology and...

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Giuseppe Gargiulo

Author

Giuseppe Gargiulo
RTC - Radial versus femoral access for coronary procedures

COVID-PACT - Antithrombotic therapy in critically Ill COVID-19 patients

02 Sep 2022

Watch Luis Ortega Paz's interview with David Berg as part of the ESC 2022 Congress coverage, and find out more about the COVID-PACT trial, which aims to study antithrombotic strategies in critically ill COVID-19 patients. Learn more about the study design (population, primary endpoint, safety criteria...)...

David Berg

Author

David Berg
Luis Ortega-Paz

Author

Luis Ortega-Paz
COVID-PACT - Antithrombotic therapy in critically Ill COVID-19 patients

Pretreatment with heparin in patients with ST-segment elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

01 Sep 2022

Daniele Giacoppo analyses the results of the SCAAR registry which compared patients with STEMI treated by primary PCI in Sweden from January 2008 to December 2016 according to the UFH pretreatment status...

Daniele Giacoppo

Author

Daniele Giacoppo
Pretreatment with heparin in patients with ST-segment elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

PACIFIC-AMI - Efficacy and safety of factor XIa inhibitor asundexian on top of dual antiplatelet therapy after acute myocardial infarction

28 Aug 2022

Ali Nazmi Calik asks trial investigator John Alexander about the design and results of the PACIFIC-AMI phase 2 trial, which revealed no increase in bleeding versus placebo.

Author

Ali Nazmi Calik

Author

John Alexander
PACIFIC-AMI - Efficacy and safety of factor XIa inhibitor asundexian on top of dual antiplatelet therapy after acute myocardial infarction

INVICTUS - Rivaroxaban versus VKA for rheumatic atrial fibrillation

28 Aug 2022

Aaysha Cader interviews Ganesan Karthikeyan who presented the results of INVICTUS during the ESC Congress 2022 in Barcelona: Among patients with rheumatic heart disease–associated atrial fibrillation, vitamin K antagonist therapy led to a lower rate of a composite of cardiovascular events or death than rivaroxaban therapy,...

Author

Aaysha Cader
Ganesan Karthikeyan

Author

Ganesan Karthikeyan
INVICTUS - Rivaroxaban versus VKA for rheumatic atrial fibrillation

The PRE18FFIR trial: Coronary Plaque Activity to Predict Recurrent Events

01 Sep 2022

Alex Sticchi provides his take on the PRE18FFIR trial: Prediction of recurrent events with 18F-Sodium Fluoride to identify ruptured and high-risk coronary artery plaques in patients with myocardial infarction.

Alessandro Sticchi

Author

Alessandro Sticchi
The PRE18FFIR trial: Coronary Plaque Activity to Predict Recurrent Events

DANFLU-1 - High-dose vs. standard-dose quadrivalent influenza vaccine in elderly adults

28 Aug 2022

Tor Biering-Sørensen talks with Aaysha Cader about the results of the DANFLU-1 trial which were presented during ESC Congress 2022 in Barcelona. In fact, elderly adults who received a high-dose quadrivalent influenza vaccine compared with a standard dose saw significantly reduced risk of death and hospitalization...

Author

Aaysha Cader
Tor Biering-Sørensen

Author

Tor Biering-Sørensen
DANFLU-1 - High-dose vs. standard-dose quadrivalent influenza vaccine in elderly adults

Relative survival after mitral TEER in MitraSwiss patients

28 Aug 2022

Mirvat Alasnag interviews Luigi Biasco, first author of the MitraSwiss Registry which was presented at the ESC Congress 2022 in Barcelona. Together, they discuss the enrolled population, the inclusion criteria, the design and outcomes of MitraSwiss, its comparison with other European registries and the restoration of...

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Luigi Biasco

Author

Luigi Biasco
Relative survival after mitral TEER in MitraSwiss Patients

PCR Tokyo Valves 2022 - A dedicated series of 6 live webinars to enjoy

28 Jun 2022

 

 

Watch replay for free now!

This year’s PCR Tokyo Valves took the form of a dedicated series of 6 live webinars. They took place from September to December 2022, last one hour each, and are all in English. They address a broad range of issues in structural...

PCR Tokyo Valves 2022 – Join your peers for a series of 6 CME-accredited live webinars!

EuroIntervention's new Impact Factor!

28 Jun 2022

The EuroIntervention Journal is pleased to announce its 2021 Impact Factor: 7.728 (2021 Journal Citation Reports® Science Edition (Clarivate Analytics, 2022)

With this result, we confirm last year's progression and we are proud to be listed 2nd amongst interventional cardiology journals. 

EuroIntervention's new Impact Factor!

What do we know about tricuspid valve disease? A case-based webinar series

04 Aug 2022

These 3 innovative PCR Webinars are the work of the PCR Tricuspid Focus Group. To learn more about this initiative’s mission and its five ongoing working groups dedicated to improving the treatment of patients with tricuspid valve disease, please click here.

Learning objectives

View this series of 3 case-based webinars if...

Timing and predictors of definite stent thrombosis in comatose survivors of out-of-hospital cardiac arrest undergoing percutaneous coronary intervention and therapeutic hypothermia (ST-OHCA study)

09 Aug 2022

The ST-OHCA study is a single centre prospective study investigating the incidence, timing and predictors of definite stent thrombosis in comatose survivors of out-of-hospital cardiac arrest (OHCA) undergoing immediate PCI and therapeutic hypothermia.

Nicola Ryan

Reviewer

Nicola Ryan
Timing and predictors of definite stent thrombosis in comatose survivors of out-of-hospital cardiac arrest undergoing percutaneous coronary intervention and therapeutic hypothermia (ST-OHCA study)

Tricuspid valve interventions: patient and device selection

09 Aug 2022

PCR Webinar on tricuspid valve disease with F. Maisano, R. von Bardeleben, J. L. Zamorano, J. Cavalcante, P. Lurz and G. Nickenig

Tricuspid valve interventions: patient and device selection

Tricuspid valve lifetime management

09 Aug 2022

Watch the replay of this PCR Webinar on tricuspid valve management with L. Sondergaard, H. Treede, N. Wunderlich, L. Conradi, J. Hausleiter and A. Latib

Imaging the journey of a patient with severe tricuspid regurgitation: from diagnosis to management

22 Dec 2021

MedAlliance SELUTION SLR Receives Second FDA IDE Approval

09 Aug 2022

The importance of hemodynamic performance in transcatheter aortic valves

04 Jul 2022

Watch the 1st of #PCRtokyo 2022’s six live webinars about ‘The importance of hemodynamic performance in transcatheter aortic valves’.

The importance of hemodynamic performance in transcatheter aortic valves

How Transcatheter Mitral therapies experience and proven outcomes are influencing real life clinical practice

10 Aug 2022

Learning objectives

Attend this series of 2 webinars if you want to:

  • Demonstrate MitraClip effectiveness and improved outcomes in broad spectrum of patients
  • Illustrate the reality in clinical practice of COAPT type patients
  • Review the real-world data from EXPAND study and new generation solution advances
  • Learn about the expanded treatment options and...

How are MitraClip experience and proven outcomes influencing real-life clinical practice?

09 Nov 2021

Discover the replay of this PCR Webinar on MitraClip with H. Ince, S. Kar, W. Rottbauer and R. von Bardeleben

Transcatheter Mitral Valve therapy : repair or replace?

13 Dec 2021

Watch the replay of this PCR Webinar on mitral valve with R. Bekeredjian, F. Maisano, F. Praz and P. Sorajja.

Didn’t find what you were looking for?